Schedule 13G ownership disclosure
Voyager Therapeutics Inc
Common Stock · CUSIP: 92915B106
Event date: 2025-03-31
- Filing-level shares
- 3,525,532
- Percent of class
- 6.4%
- BlackRock, Inc.
Shares: 3,525,532 · Class: 6.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-001565
- Form type
- SCHEDULE 13G/A
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Apr 24, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership